Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
May 11, 2017 12:03 pm UTC| Business
SAN DIEGO, May 11, 2017 -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the...
Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 11, 2017 12:02 pm UTC| Business
--Raised ~$20 million through an underwritten equity offering -- -- Factor IX Hemophilia B program milestone payment received after completion of IND-enabling toxicology studies -- -- Initiation of Hemophilia B Phase...
Advanced Energy Partners with Innosphere on Innovation Pipeline
May 11, 2017 12:02 pm UTC| Business
FORT COLLINS, Colo., May 11, 2017 -- Advanced Energy Industries, Inc. (Nasdaq:AEIS), the global leader in precision power conversion, announced that, as part of its focus on innovation, the company is now collaborating...
May 11, 2017 12:02 pm UTC| Business
PARIS, May 11, 2017 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat ageing diseases, has announced that it has received the approval from the US...
Advanced Energy Partners with Innosphere on Innovation Pipeline
May 11, 2017 12:02 pm UTC| Business
FORT COLLINS, Colo., May 11, 2017 -- Advanced Energy Industries, Inc. (Nasdaq:AEIS), the global leader in precision power conversion, announced that, as part of its focus on innovation, the company is now collaborating...
Advanced Energy Partners with Innosphere on Innovation Pipeline
May 11, 2017 12:02 pm UTC| Business
FORT COLLINS, Colo., May 11, 2017 -- Advanced Energy Industries, Inc. (Nasdaq:AEIS), the global leader in precision power conversion, announced that, as part of its focus on innovation, the company is now collaborating...
May 11, 2017 12:02 pm UTC| Business
PARIS, May 11, 2017 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat ageing diseases, has announced that it has received the approval from the US...